Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gilead Sciences

109.81
+0.51000.47%
Volume:2.12M
Turnover:232.34M
Market Cap:136.60B
PE:23.21
High:110.54
Open:110.49
Low:108.90
Close:109.30
Loading ...

Gilead Sciences to Present at Upcoming Investor Conferences

Business Wire
·
30 Apr

Gilead Sciences to Pay $202 Million in Settlement of Illegal Kickbacks Lawsuit

MT Newswires Live
·
30 Apr

U.S. Attorney in Manhattan Announces $202 Mln Settlement With Gilead Sciences for Using Speaker Programs to Pay Kickbacks to Doctors

THOMSON REUTERS
·
30 Apr

Gilead Sciences reaches $202 million settlement with US over kickbacks to doctors

Reuters
·
30 Apr

Gilead Sciences (NasdaqGS:GILD) Showcases Promising Liver Disease Treatments At EASL Congress

Simply Wall St.
·
30 Apr

Gilead Sciences: AIDSVu Online Mapping Tool Helps Visualize HIV’s Impact in the United States

ACCESS Newswire
·
29 Apr

Gilead to Present Latest Advancements Across Primary Biliary Cholangitis and Viral Hepatitis

Business Wire
·
29 Apr

Contineum Therapeutics Appoints Timothy Watkins, M.D., M.Sc., as Chief Medical Officer and Head of Development

Business Wire
·
29 Apr

Wall Street's New Tariff Safe Haven: High-Tax Biotech Stocks

Dow Jones
·
28 Apr

Gilead Sciences First Quarter 2025 Earnings: Misses Expectations

Simply Wall St.
·
26 Apr

Gilead Sciences’ Earnings Call: Growth Amid Challenges

TIPRANKS
·
26 Apr

Gilead Sciences Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
26 Apr

Gilead Delivers Lackluster Q1 Revenue on Trodelvy Miss, Oppenheimer Says

MT Newswires Live
·
25 Apr

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2025-04-25

Reuters
·
25 Apr

GILD Down on Q1 Earnings and Sales Miss, Oncology Sales Decline

Zacks
·
25 Apr

Goldman Sachs Adjusts Gilead Sciences Price Target to $100 From $97, Maintains Neutral Rating

MT Newswires Live
·
25 Apr

Q1 2025 Gilead Sciences Inc Earnings Call

Thomson Reuters StreetEvents
·
25 Apr

Gilead Shares Down 3.6% After Quarterly Revenue Miss

THOMSON REUTERS
·
25 Apr

Pre-Bell | US Stock Futures Slip; Alphabet Rises 4%; Meta, AppLovin up 3%; Tesla Jumps 1%; Intel Falls 7%

Tiger Newspress
·
25 Apr

Morgan Stanley Raises Price Target on Gilead Sciences to $135 From $130, Keeps Overweight Rating

MT Newswires Live
·
25 Apr